FDA Inspection
Utah Lions Eye BankUtah Lions Eye Bank – FDA Inspection, Apr 23, 2024
Record Details
This FDA Inspection record concerns Utah Lions Eye Bank, with an inspection on April 23, 2024, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 6f411f23-3465-485d-9339-0bc5f14c1074
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1236679
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
2- 21 CFR 1271.160(b)(6)Deviations--evaluation, cause, corrective action
- 21 CFR 1271.270(a)Records incomplete
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Utah Lions Eye Bank
4| Date | Classification | Office | Project area |
|---|---|---|---|
| March 14, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 22, 2015 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| April 6, 2012 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| May 25, 2010 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Utah Lions Eye Bank
- FDA Inspection 1047605 - 2018-03-14
- FDA Inspection 980714 - 2015-09-22
- FDA Inspection 778382 - 2012-04-06
- FDA Inspection 663395 - 2010-05-25
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.